Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation.
Aurigemma C, Costa G, Laterra G, Pilgrim T, Amat Santos IJ, De Backer O, Kim WK, Barbosa Ribeiro H, Saia F, Bunc M, Tchetche D, Garot P, Ribichini FL, Mylotte D, Watanabe Y, Bedogni F, Tesorio T, Rheude T, Sardella G, Tocci M, Franzone A, Valvo R, Sammartino S, Savontaus M, Wienemann H, Porto I, Gandolfo C, Iadanza A, Mach M, Latib A, Biasco L, Taramasso M, De Marco F, Frittitta V, Dipietro E, Reddavid C, Strazzieri O, Agnello F, Comis A, Calì M, Abdel-Wahab M, Stefanini GG, Tomii D, Nuyens P, Sondergaard L, Bortone AS, Zimarino M, Camara SF, Palmerini T, Orzalkiewicz M, Steblovnik K, Gautier A, Del Sole PA, Mainardi A, Lunardi M, Kawashima H, Criscione E, Cesario V, Biancari F, Zanin F, Esposito G, Adam M, Grube E, Baldus S, De Marzo V, Piredda E, Cannata S, Iacovelli F, Andreas M, Angellotti D, Sgroi C, Xhepa E, Kargoli F, Tamburino C, Burzotta F, Barbanti M; REVASC-TAVI Registry.
Aurigemma C, et al.
Circ Cardiovasc Interv. 2026 May 20:e015770. doi: 10.1161/CIRCINTERVENTIONS.125.015770. Online ahead of print.
Circ Cardiovasc Interv. 2026.
PMID: 42158982
Free article.